Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01610583 · ClinicalTrials.gov registry record
Testing Spanish-language Genetic Literacy
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 117
- Enrollment target
NCT01610583: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT01610583 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01610583 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
Background: * Health literacy means being able to understand basic health care information. This information can include drug labels and prescription instructions. It can also include doctor s instructions. Better health literacy can help improve a person s health outcomes. * Many minorities have low health literacy. Latinos in particular have both low health literacy and poor health outcomes. Language barriers such as poor reading skills can contribute to problems with health literacy. Researchers want to develop a new health literacy measuring tool. This tool will focus on genetic literacy, which involves understanding personal risk of health problems. The tool will be written in Spanish. The study will work with Spanish-speaking Latinos to develop and test this genetic literacy tool. Objectives: \- To develop a Spanish-language tool to study genetic literacy. Eligibility: \- Spanish-speaking Latino adults between 18 and 75 years of age. Design: * Participants will be screened with a brief interview. No personal samples will be needed. * Participants will complete the genetic literacy questionnaire. It will be given in Spanish. * The tool will ask about participants personal and family health history. It will also ask about their understanding of genetic terms and genetic testing. Other personal information, such as level of education, will be collected. * Participants will receive a gift card for completing the survey. * No treatment or genetic counseling will be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2012-05-24 |
| Est. Completion | 2015-02-23 |
What the finished NCT01610583 record still lists
NCT01610583 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01610583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01610583 about?
NCT01610583 is a clinical study titled "Testing Spanish-language Genetic Literacy". Background: * Health literacy means being able to understand basic health care information. This information can include drug labels and prescription instructions. It can also include doctor s instructions. Better health literacy can help improve a person s health outcomes. * Many minorities have l...
What is the current status of trial NCT01610583?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2012-05-24. Estimated completion is 2015-02-23.
Who is sponsoring clinical trial NCT01610583?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI